Newsletter Signup | Join Community
Stage II Melanoma is treated with surgery and some individuals may benefit from adjuvant therapy.
BRAF-MEK combination double survival in advanced melanoma with V600E and V600K mutations
Keytruda® Continues to have Improved Survival Benefit Compared to Yervoy® in Advanced Melanoma.
Yervoy + Opdivo Improves Overall Survival in Advanced Melanoma; Average Survival May Exceed 4 Years
Keynote 054 clinical trial establishes Keytruda as standard treatment for stage III melanoma and leads to FDA approval.
Immunotherapy effective as treatment of melanoma spread to brain, researchers advocate combinations of drugs.
Stay Current With Melanoma Treatment Advances & Connect with Others
Research suggests that adjuvant radiation may reduce melanoma recurrences in stage III patients at risk of local relapse
Cancer Connect - Treatment of In Situ & Stage 1 Melanoma
Biomarkers drive new drug development in melanoma
Anyone have experience with TVEC? Looking to learn from others. Thanks
A new very active treatment option for Melaoma-Braftovihttps://mavendoctors…